X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Torrent Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
TEVA PHARMA
Dec-13
TORRENT PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5502,983-   
Low Rs1,1442,591-   
Sales per share (Unadj.) Rs354.71,711.8-  
Earnings per share (Unadj.) Rs40.1106.9-  
Cash flow per share (Unadj.) Rs64.2245.3-  
Dividends per share (Unadj.) Rs14.0093.61-  
Dividend yield (eoy) %1.03.4 30.9%  
Book value per share (Unadj.) Rs273.11,901.5-  
Shares outstanding (eoy) m169.22848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.81.6 233.2%   
Avg P/E ratio x33.626.1 128.9%  
P/CF ratio (eoy) x21.011.4 184.6%  
Price / Book Value ratio x4.91.5 336.4%  
Dividend payout %34.987.5 39.9%   
Avg Mkt Cap Rs m227,8972,363,325 9.6%   
No. of employees `00014.744.9 32.7%   
Total wages/salary Rs m11,3530-   
Avg. sales/employee Rs Th4,083.032,298.1 12.6%   
Avg. wages/employee Rs Th772.30-   
Avg. net profit/employee Rs Th461.32,017.6 22.9%   
INCOME DATA
Net Sales Rs m60,0211,451,638 4.1%  
Other income Rs m2,9880-   
Total revenues Rs m63,0091,451,638 4.3%   
Gross profit Rs m13,493397,532 3.4%  
Depreciation Rs m4,086117,337 3.5%   
Interest Rs m3,08528,513 10.8%   
Profit before tax Rs m9,310251,682 3.7%   
Minority Interest Rs m01,143 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,216 0.0%   
Tax Rs m2,529-3,073 -82.3%   
Profit after tax Rs m6,78190,683 7.5%  
Gross profit margin %22.527.4 82.1%  
Effective tax rate %27.2-1.2 -2,224.7%   
Net profit margin %11.36.2 180.9%  
BALANCE SHEET DATA
Current assets Rs m52,623980,431 5.4%   
Current liabilities Rs m52,022855,019 6.1%   
Net working cap to sales %1.08.6 11.6%  
Current ratio x1.01.1 88.2%  
Inventory Days Days12091 131.7%  
Debtors Days Days7696 79.5%  
Net fixed assets Rs m85,016474,137 17.9%   
Share capital Rs m8463,573 23.7%   
"Free" reserves Rs m45,3760-   
Net worth Rs m46,2221,612,495 2.9%   
Long term debt Rs m41,115742,255 5.5%   
Total assets Rs m142,4323,317,459 4.3%  
Interest coverage x4.09.8 40.9%   
Debt to equity ratio x0.90.5 193.2%  
Sales to assets ratio x0.40.4 96.3%   
Return on assets %6.93.6 192.8%  
Return on equity %14.75.6 260.9%  
Return on capital %14.24.9 287.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,9800-   
CASH FLOW
From Operations Rs m8,942231,316 3.9%  
From Investments Rs m-47,070-81,965 57.4%  
From Financial Activity Rs m34,174-277,479 -12.3%  
Net Cashflow Rs m-3,655-128,128 2.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.46 Rs / USD

Compare TORRENT PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare TORRENT PHARMA With: FDC LTD.  BIOCON LTD  WYETH LTD  DISHMAN PHARMA  J.B.CHEMICALS  



Today's Market

US-China Trade Talks, Oil Prices, and Top Stocks in Action Today(Pre-Open)

On Tuesday, share markets in India witnessed selling pressure during closing hours and ended their trading session marginally lower after a volatile day of trading.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Feb 19, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS